Latest News

Health Canada Accepts Arcutis Canada's Submission for Roflumilast Cream 0.15% in Atopic Dermatitis
Health Canada Accepts Arcutis Canada's Submission for Roflumilast Cream 0.15% in Atopic Dermatitis

May 28th 2024

Supportive data for roflumilast in adults and children 6 years of age and older stems from the INTEGUMENT studies.

Pharmacists May Require Additional Training on Corticophobia in Atopic Dermatitis
Pharmacists May Require Additional Training on Corticophobia in Atopic Dermatitis

May 24th 2024

Image credit: © Aamulya - stock.adobe.com
RECAP Measurement Validated for Atopic Dermatitis

May 20th 2024

Baldo Scassellati Sforzolini, MD, PhD, MBA: Expanding Nemolizumab’s Access
Baldo Scassellati Sforzolini, MD, PhD, MBA: Expanding Nemolizumab’s Access

May 17th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.